Background: Vitiligo is characterized by a lack of pigmentation in the skin. To date, there are no studies that analyze the changes in gene expression in the skin of vitiligo patients in response to narrow-band ultraviolet B (nb-UVB) phototherapy treatment. oBjective: Explore the usefulness of new generation RNA sequencing in the identification of gene expression changes in the skin of vitiligo patients treated with nb-UVB phototherapy. Methods: Four skin biopsies (4mm in diameter) were collected from 45 Mexican vitiligo vulgaris patients, 2 specimens before and 2 after treatment with nb-UVB phototherapy, obtained from pigmented and non-pigmented tissue. RNA extracted from the biopsies was analyzed using the Illumina TruSeq Targeted RNA Expression protocol to study the expression of genes that participate in pathways of skin homeostasis. The 2 groups were compared using Student's t-test and the Mann-Whitney U-test. results: The expression analysis identified differences in 12 genes included in this study after comparing the samples obtained before and after treatment: 5 genes involved in skin pigmentation, 2 genes involved in apoptosis, 2 genes involved in cell survival, 2 genes involved in oxidative stress responses and 1 gene involved in signal transduction mechanisms (p<0.05). study liMitations: The small size of skin biopsies limits the amount of RNA obtained, the number of genes to be analyzed and the use of conventional techniques such as RT-qPCR. conclusion: We demonstrated usefulness of new generation RNA sequencing in the identification of gene expression changes, in addition to identifying new targets in the study of vitiligo.
INTRODUCTION
Vitiligo belongs to a family of cutaneous diseases, characterized by a lack of pigmentation in the skin. 1 This disease affects between 0.1% and 2% of the world's population; however, its incidence varies considerably among the populations or ethnic groups analyzed and is estimated to be 0.14% in Russia, between 1% and 2.5% in the United States and Japan,² and high in Mexico (4%) and India (8.8%).¹ ,
³
The causes of vitiligo are complex and not yet fully understood. Several hypotheses and theories have been developed to explain the depigmentation and melanocyte destruction observed in this condition; however, these theories do not explain the full spectrum of this disease. 4 Thus, the clinical data, embryonic origin of the melanocytes, association with autoimmune disorders, and presence of relatives affected with this disease, among other factors, should investigAtion An Bras Dermatol. 2018;93 (6) :843-51.
be considered, suggesting that vitiligo results from a combination of environmental, autoimmune and genetic factors, and several theories have been proposed. 5, 6 Studies worldwide have explored genes that are potentially involved in the development of vitiligo and other autoimmune diseases using gene expression analysis studies, candidate gene association studies, genetic linkage studies, and genomic association studies (GWAS). 7 Gene expression studies performed on skin biopsies obtained from patients with vitiligo have enabled the analyses of changes in the expression patterns of several genes associated with immunomodulation, 7 melanogenesis, and regulation of the development and survival of melanocytes. [8] [9] [10] [11] To date, no fully effective treatment for vitiligo has been identified. Techniques promoting repigmentation have been used, such as narrow-band ultraviolet B light (nb-UVB), which is currently considered the treatment of choice for vitiligo. 12 This therapy uses a light spectrum of 311nm, presenting a penetrance to the basal layer of the epidermis, which induces local immunosuppression and stimulates the proliferation of melanocytes in the skin and in the external epithelial root sheath of the hair follicle, thereby stimulating melanogenesis and the production of melanocyte-stimulating hormone (MSH). [12] [13] [14] Currently, there are no studies analyzing the changes in ditions. [15] [16] [17] [18] In particular, RNA-seq using next-generation sequencing (NGS) also facilitates a more accurate measurement of the levels of transcript expression, even the presence of isoforms in the analyzed samples. 19 TruSeq RNA Targeted sequencing can effectively detect changes in patterns of gene expression by simultaneously analyzing a large variety of selected targets with custom designs, using smaller sample amounts, shorter processing times and lower costs than other technologies (qPCR and Microarray). 20, 21 This technology has previously been applied in the identification of expression profiles in other dermatological diseases, such as psoriasis and lupus erythematosus, suggesting that TruSeq RNA Targeted sequencing could be a useful tool for vitiligo. [22] [23] [24] However, the discrimination power of this method has not been explored in vitiligo.
In a previous study conducted by our research group on skin biopsies obtained from a smaller number of untreated vitiligo patients and healthy controls, we detected changes in the expression of the genes involved in a wide variety of biological processes, including signaling, apoptosis, oxidative stress control, cell survival and pigmentation (unpublished data). Using the information from the gene expression profiles and the addition of other genetic targets identified by the previously mentioned methods, valuable information concerning gene expression patterns, clinical classification, and the effectiveness of the treatment could be obtained using RNA-seq.
Thus, the objective of the present study was to explore the use of RNA-seq technology for the identification of changes in the expression profiles of selected genes in skin biopsies obtained from vitiligo patients before and after treatment with nb-UVB; the present study used NGS TruSeq Targeted RNA Expression from Illumina. If the patient presented any reaction, then this dose was decreased to the previous tolerated dose.
METHODS
Treatment follow-up was documented through baseline iconography and at 1, 3 and 6 months after initiation of treatment. The clinical results (i.e., changes of repigmentation experienced by the patient after 6 months of treatment) were evaluated by 2 independent and double-blind investigators.
The iconography was obtained using a Sony Exmor DSC-HX1 9.1 megapixel camera (Shinagawa-ku, Tokyo, Japan). 
Biological samples

Verification of RNA quantity and quality
The amount of total RNA was determined using spectrophotometric microvolume quantification using a NanoDrop 8000 
Analysis of gene expression
The cDNAs generated from the skin biopsies of patients before and after treatment were used to perform the expression anal- 
Statistical analysis
The collected data were analyzed using SPSS software version 17.0 (SPSS, Inc. Chicago, IL, USA). For the demographic data and to define the variables, descriptive statistics were used for both the vitiligo injury group and the normal skin group. To examine normality, Kolmogorov-Smirnov and Shapiro-Wilk tests were performed. According to the type of distribution presented by the groups (normal or non-normal), the 2 groups were compared using Student's t-test and the Mann-Whitney U-test. A value of P ≤ 0.05 was considered significant. 
RESULTS
Demographic analysis
Expression analysis
The heat maps generated after comparing the expression patterns from the samples obtained before and after treatment ( Figure   1 ) enabled the identification of differences between the expression patterns of pigmented skin (not affected, and repigmented after treatment) and non-pigmented skin (vitiligo and tissue sample that did not repigment), organized into 2 main clades in the heat map.
In addition, significant expression patterns were found in three pigment-related genes: DopachromeTautomerase (DCT),
Melan-A (MLANA) and Tyrosinase-Related Protein (TYRP1) gene, which are over expressed in pigmented skin (p<0.05).
When grouping the samples according to the type and subtype of pigmentation (with pigment and without pigment), gender (female or male), age, type of vitiligo (active or stable), and degree of response to treatment (less than 10% improvement, 10%-30% improvement and more than 30% improvement), we observed the same patterns of over expression in DCT, MLANA and TYRP1
genes (related to skin pigmentation) ( Figure 2 ).
No differences in the type of vitiligo were observed among skin samples from subjects with active or stable vitiligo. Encodes an integral outer mitochondrial membrane protein that blocks apoptotic death
Involved in the regulation of cell proliferation and contributes to transcriptional regulation of NFKB CASP3 25, 29 Is a member of the cysteine-aspartic acid protease (caspase) family; plays a central role in the execution-phase of cell apoptosis Tumor necrosis factor, involved in the regulation of a wide spectra of biological processes, including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation TNFRSF1A For genes involved in apoptosis mechanisms, we observed differences in two of the genes selected for this study (p <0.05), CASP3
(cysteine protease 3, processed by caspases 8, 9 and 10 and participat- (Table 1 ). Both genes were over expressed in the skin of patients with vitiligo, suggesting that the induction of an extrinsic mechanism of apoptosis is involved in the pathogenic mechanism of vitiligo.
However, the analysis of the expression patterns of the genes involved in melanocyte mechanisms (Table 1) the expression of genes related to melanin synthesis and melanocyte survival) was higher for pigmented tissues (non-affected and repigmented after treatment) compared to vitiligo skin before treatment and in affected skin that did not repigment after treatment (Table 1) .
When analyzing the genes involved in responses to oxidative stress (Table 1) , the GPD1 gene (involved in the Redox metabolism of the cell) was over expressed in tissue that did not repigment after treatment. The TXN gene (involved in the inhibition of oxidative stress and activation of caspase 3) was over expressed in vitiligo skin and affected skin that did not repigment, accounting for the activation of mechanisms in response to apoptosis and oxidative stress generated by this cell death mechanism.
Finally, gene-related signaling pathways and signal translation mechanisms showed statistically significant differences when comparing the mean expression patterns observed for the CSNK1G3 gene when analyzing vitiligo and affected skin that did not repigment after treatment, which was reduced in the latter case ( Table   1 ). The product of the CSNK1G3 gene is a serine/threonine kinase that phosphorylates several proteins involved in the Wnt pathway, participating in cellular processes such as DNA repair, cell division, nuclear localization and membrane transport: all active processes in the cells of the skin and potentially involved in the synthesis, transport and storage of the pigment.
DISCUSSION
In this research, a group of genes involved in skin pigmentation, apoptosis and cell survival, oxidative stress and signal transduction were selected to identify changes in the expression patterns of these genes in the skin of vitiligo patients undergoing treatment with nb-UVB phototherapy. Until recently, the relationship between the skin expression patterns of a group of genetic markers participating in the main routes involved in vitiligo, patients affected by this condition and responses to experienced standard treatments had not been documented.
For this purpose, nb-UVB phototherapy was applied for 6 months, which is considered the standard treatment for vitiligo vulgaris because of its effectiveness and safety. For the genes involved in responses to oxidative stress, the GPD1 gene, involved in the oxidation-reduction metabolism of the cell (redox), 38 was over expressed in tissue that repigmented after treatment. The TXN gene, involved in the inhibition of oxidative stress and activation of caspase 3, is over expressed in vitiligo and non-repigmented tissues, suggesting potential activation mechanisms in response to apoptosis and oxidative stress generated through mechanisms of cell death.
To date, only changes in the levels of TXN protein in the skin of vitiligo patients, 39 and their relationship to the control of reactive oxygen species production and UV damage have been reported. 47 The involvement of the GPD1 gene in the control of oxidative stress in vitiligo has not yet been explored.
Finally, the involvement of the WNT pathway in melanocyte differentiation and the development of vitiligo has recently been described. 30 However, in our study, only statistically significant 
CONCLUSION
The nb-UVB phototherapy produced significant changes in the expression patterns of the genes analyzed, primarily reflecting repigmentation and cellular apoptosis control.
Expression analysis revealed significant differences in the expression patterns of the DCT, MLANA and TYRP1 genes in pigmented skin (unaffected and affected then repigmented after treatment) compared to affected skin (vitiligo and non-pigmented skin after treatment). The statistical analysis of the expression patterns obtained using TruSeq Targeted RNA Expression technology from skin samples obtained before and after treatment showed changes in the expression profiles in selected genes in response to nb-UVB phototherapy, and some of these changes were comparable with those previously reported by other research groups, particularly in genes related to skin pigmentation.
In addition, the identification of novel targets genes, including TNFRS1A, GPD1 and CSNK1G3, implicated in apoptosis, oxidative stress control and signal transduction, suggests that these genes play a central role in many aspects of vitiligo development.
